Stephanie Speaker

Pembrolizumab for patients with melanoma or non-small-cell lung cancer and untreated brain metastases: early analysis of a non-randomised, open-label, phase 2 trial.

A. Vortmeyer, R. Herbst, A. Chiang, 2016, The Lancet. Oncology.

A Phase II trial of pembrolizumab for patients with melanoma or non-small cell lung cancer and untreated brain metastases

Upendra, Chiang, A. Vortmeyer, 2017 .

Activity and safety of pembrolizumab in patients with metastatic non-small cell lung cancer with untreated brain metastases.

A. Vortmeyer, R. Herbst, A. Chiang, 2015 .

Safety and activity of pembrolizumab in melanoma patients with untreated brain metastases.

A. Vortmeyer, M. Sznol, H. Kluger, 2015 .